The U.S. Food & Drug Administration said on Friday it had approved Eli Lilly’s injected drug tirzepatide, which has the brand name Mounjaro, to help improve blood sugar control in adults with type 2 diabetes.
in Health care
Here you'll find all collections you've created before.
GIPHY App Key not set. Please check settings